You are here

From Basic Science to Better Medicines: A Conversation with Congresswoman Katherine Clark

Monday, April 23, 2018
10:00 am

Read the feature piece on the panel: What’s the Link Between Public Funding and Scientific Breakthroughs? Bentley Hosts Event with Congresswoman Katherine Clark and Biotech Executives

Bentley’s Center for Integration of Science and Industry recently published a study in the Proceedings of the National Academy of Sciences that showed the National Institutes of Health (NIH) invested more than $100 billion in research that led to new medicines in the last decade. Significantly, NIH funding contributed to the basic science leading to every one of these new medicines.

We are honored that Massachusetts Congresswoman Katherine Clark visited Bentley for a conversation about the essential role of government in funding basic biomedical science, and how the biotechnology industry builds on this science to create new medicines, jobs, and successful companies.

Professor Fred Ledley, Bentley University 


  • Moderated by Center Director and Professor Fred Ledley
  • Ekaterina Cleary, research associate and lead author of the PNAS study
  • Deborah Dunsire, CEO of Xtuit Pharmaceuticals
  • Chris Garabedian, CEO of Xontogeny
  • Mark Namchuk, SVP of Research, Pharmaceutical and Non-clinical Development at Alkermes
  • Lance Colwell, Vice President US Rare Disease Group at Biogen
  • Massachusetts Congresswoman Katherine Clark